Prospective observational study to predict sensitive marker after administration of nintedanib in patients with idiopathic pulmonary fibrosis
Latest Information Update: 28 May 2016
At a glance
- Drugs Nintedanib (Primary)
- Indications Pulmonary fibrosis
- Focus Biomarker; Pharmacodynamics
- 28 May 2016 New trial record